George Green, Head of Pharmacodiagnostics at Bristol Meyers Squibb, joins Beyond the Scope to discuss the pharmaceutical industry's perspective on digital pathology and artificial intelligence. The conversation revolves around how digital pathology will see increased applications in the current era of precision medicine. 1:22 Introduction 4:15 The companion diagnostics revolution in pharma9:54 Early applications of digital pathology in pharma14:38 How the mindset of pathologists has evolved since the dawn of DP/AI19:55 Pharma perspective on how DP/AI will drive the future of precision medicine25:00 Increasing DP adoption in the pharma industry28:40 Digital pathology bringing better patient care around the world